These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31831565)

  • 41. A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety.
    Wang Y; Wu KC; Zhao BX; Zhao X; Wang X; Chen S; Nie SF; Pan WS; Zhang X; Zhang Q
    J Biomed Biotechnol; 2011; 2011():854872. PubMed ID: 21331356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
    Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q
    J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
    Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
    Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy.
    Wang H; Wang S; Wang R; Wang X; Jiang K; Xie C; Zhan C; Wang H; Lu W
    Nanoscale; 2019 Jul; 11(27):13069-13077. PubMed ID: 31265023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and
    Zeng W; Kwan Law BY; Wai Wong VK; Bik Chan DS; Fai Mok SW; Ying Gao JJ; Yan Ho RK; Liang X; Li JH; Lee MT; Yoon WL; Smolinski MP; Nam Lau JY; Kei Lam CW; Fok M
    Cancer Biol Med; 2020 Nov; 17(4):986-1001. PubMed ID: 33299648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.
    Chowdhury MR; Moshikur RM; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
    Int J Pharm; 2019 Jun; 565():219-226. PubMed ID: 31077761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
    Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
    Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol.
    Huang ST; Wang YP; Chen YH; Lin CT; Li WS; Wu HC
    Int J Oncol; 2018 Sep; 53(3):1105-1117. PubMed ID: 29956746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation.
    Koot D; Cromarty D
    Drug Deliv Transl Res; 2015 Jun; 5(3):257-67. PubMed ID: 25795051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
    Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model.
    Bressand D; Novell A; Girault A; Raoul W; Fromont-Hankard G; Escoffre JM; Lecomte T; Bouakaz A
    Mol Pharm; 2019 Sep; 16(9):3814-3822. PubMed ID: 31356090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue.
    Lei C; Davoodi P; Zhan W; Chow PK; Wang CH
    J Pharm Sci; 2019 May; 108(5):1736-1745. PubMed ID: 30552956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
    Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of the anticancer activities of paclitaxel by Cremophor micelles.
    Chiang JL; Yang YW
    Int J Pharm; 2021 Jun; 603():120699. PubMed ID: 33992713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
    Li Y; Zheng X; Gong M; Zhang J
    Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
    Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
    J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
    Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J
    Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coloaded Nanoparticles of Paclitaxel and Piperlongumine for Enhancing Synergistic Antitumor Activities and Reducing Toxicity.
    Liu Q; Zhao D; Zhu X; Chen H; Yang Y; Xu J; Zhang Q; Fan A; Li N; Guo C; Kong Y; Lu Y; Chen X
    J Pharm Sci; 2017 Oct; 106(10):3066-3075. PubMed ID: 28552690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.